Hypertension Secondary Clinical Trial
Official title:
Primary Aldosteronism In Hypertensive Patients in China
To investigate the prevalence of primary aldosteronism (PA) in Chinese patients with newly diagnosed hypertension.
This is a nationwide sampling study. To investigate the prevalence of primary aldosteronism (PA) in Chinese patients with hypertension, we will conduct a case detection of PA in Chinese hypertensive patients from 10 centers of China (including Beijing, Chongqing, Shanghai, Guangzhou, et al.); furthermore, a case confirmation of PA (captopril challenge test and saline infusion test) will be performed if the result of case detection is positive. This study will be completed in two years. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05539443 -
Telehealth-Enhanced Assessment and Management After Stroke-Blood Pressure
|
N/A | |
| Active, not recruiting |
NCT03753633 -
Efficiency of Speech Therapy in Resistant Hypertensive Patients With Mild Obstructive Sleep Apnea Syndrome
|
N/A | |
| Active, not recruiting |
NCT04646902 -
Kynurenine/Tryptophan Ratio in Hypertension Associated to Obstructive Sleep Apnea
|
||
| Completed |
NCT03105531 -
Screening for Primary Aldosteronism in a Population of Patients With Hypertension
|
||
| Completed |
NCT03246022 -
Characteristics of Obstructive Sleep Apnea Syndrome Related Hypertension and the Effect of Continuous Positive Airway Pressure Treatment on Blood Pressure
|